Colon Cancer News and Research

Latest Colon Cancer News and Research

Acetylsalicylic acid, the active ingredient in Aspirin can lower the risk of redeveloping colorectal cancer

Acetylsalicylic acid, the active ingredient in Aspirin®, can lower the risk of redeveloping colorectal cancer: Stage III colon cancer patients, who have undergone surgery and chemotherapy, experience less recurrence and fatalities when using Aspirin®.

4 Jul 2005

Medical experts say that yearly checkup not necessary - doctors and patients disagree

Though you and your doctor might think that yearly checkup is just a routine part of staying healthy, that practice isn't endorsed by a panel of experts.

29 Jun 2005

Brief course of chemotherapy after surgery should be the new standard of care around the world

A Canadian national clinical trial has found that chemotherapy following surgery for early-stage non-small cell lung cancer significantly improves survival for the disease over just surgery alone.

27 Jun 2005

Double whammy of chemo plus surgery extends life for lung cancer patients

Recent research which has shown that chemotherapy can significantly lengthen life in many patients with lung cancer, has meant that doctors, for the first time in decades, have begun making major changes in the treatment of the disease.

23 Jun 2005

Keyhole surgery can be safely used for the removal of tumours from the colon

The safety and short-term benefits of keyhole surgery for colon cancer have been debatable. Minimally invasive surgery for cancer reduces surgical trauma but there has been concern that it could lead to tumour recurrence.

20 Jun 2005

Claudin-1 regulates cellular transformation and metastatic behavior in colon cancer

Disruption of proteins expressed at the junctures between cells (known as tight junctions) is a hallmark of cancer cell invasion and spread (metastasis).

16 Jun 2005

FDA approves Xeloda (capecitabine) oral chemotherapy

Roche announced today that the U.S. Food and Drug Administration (FDA) has approved Xeloda (capecitabine) -- an innovative oral chemotherapy -- for the adjuvant (post-surgery) treatment of patients with Dukes' C colon cancer.

15 Jun 2005

New survey shows Americans falling short on sun protection

Over the past year, the number of Americans using sunscreen, a primary protector against skin cancer, has declined. At the same time, more Americans, including children, are being diagnosed with skin cancer than ever before.

6 Jun 2005

Every U.S. child and adult will be obese by 2044

Advertisements on television and in newspapers consistently hype the latest diet fads. News reports comment on the latest research about the negative effects of obesity on Americans.

2 Jun 2005

New study linking pain relievers and breast cancer fails to convince experts

Research in recent years has consistently linked the use of aspirin and other anti-inflammatory pain relievers with a lower risk of colon cancer, but findings about the drugs' effect on breast-cancer risk have been very mixed with some studies suggesting that the pain relievers protect against breast cancer, while others have found no link.

1 Jun 2005

Statin drugs prescribed for heart disease also reduce the risk of colon cancer

According to new research released this week people taking statin drugs to control the progression of heart disease may be getting the extra benefit of protection from colorectal cancer.

25 May 2005

Medical imaging costs at a steady percentage of overall hospital costs

The substantial increase in the use of medical imaging during recent years has fueled speculation that imaging costs were a major factor behind the rise in overall health care costs.

24 May 2005

Sigmoidoscopy comes up short for women in detection of polyps in the colon

A new multi-center study has reaffirmed the difference between the sexes – at least when it comes to colorectal cancer detection and prevention.

20 May 2005

Colon cancer missed in simple screening test

A new U.S. study has revealed that a commonly used screening tool for colon cancer, sigmoidoscopy, does not pick up precancerous growths in almost two-thirds of women and the failure rate is twice as high as in men.

18 May 2005

New blood tests for both prostate and colon cancer

Tessera Inc., a Seattle-based biomedical company is, in collaboration with Dr. Robert Getzenberg, Director of the Brady Urological Research Institute at Johns Hopkins University, developing blood tests for both prostate and colon cancer and expects to commence clinical trials on EPCA (Early Prostate Cancer Antigen), its first blood test for prostate cancer, before the end of this year.

18 May 2005

Regular exercise helps early stage colon cancer patients recover

Patients treated for early stage colon cancer fared significantly better if they exercised regularly at the level of an hour's walk six times a week, according to a study to be presented at the annual meeting of the American Society of Clinical Oncology.

17 May 2005

Statin chemoprevention with minimal surveillance could prevent 96 percent of colon cancers

Ulcerative colitis affects about one out of every 2,000 Americans, and after living with the disease for 30 years, nearly 22 percent of those people will develop colon cancer.

16 May 2005

Bevacizumab (Avastin) combined with low-dose chemotherapy slows ovarian cancer

A targeted cancer drug given with low-dose chemotherapy shrank ovarian tumors and slowed progression of ovarian cancer in patients with recurrent disease, according to research findings presented by Agustin Garcia, M.D., principal investigator of the study and Director of Breast Cancer Research at the Women's Cancer Research Institute at the Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center.

16 May 2005

Colon cancer patients who took aspirin regularly fared better after surgery

Colon cancer patients who took aspirin regularly fared better after surgery, reducing their risk of disease recurrence and death by half compared to non-users, researchers will report at the annual meeting of the American Society of Clinical Oncology.

16 May 2005

Counting number of endothelial cells in blood may predict cancer treatment's effectiveness

Counting the amount of a type of normal cell circulating in the blood of people with cancer could predict whether a tumor progresses or responds to therapy, a new study led by the University of Michigan Comprehensive Cancer Center has found. The finding could give doctors an early indication of whether a treatment will be successful, sparing patients months of an ineffective therapy.

15 May 2005